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Background: This study was design to investigate the prognostic value for death at day-28 of lactate course and
lactate clearance during the first 24 hours in Intensive Care Unit (ICU), after initial resuscitation.
Methods: Prospective, observational study in one surgical ICU in a university hospital. Ninety-four patients
hospitalized in the ICU for severe sepsis or septic shock were included. In this septic cohort, we measured blood
lactate concentration at ICU admission (H0) and at H6, H12, and H24. Lactate clearance was calculated as followed:
[(lactateinitial - lactatedelayed)/ lactateinitial] x 100%].
Results: The mean time between severe sepsis diagnosis and H0 (ICU admission) was 8.0 ± 4.5 hours. Forty-two
(45%) patients died at day 28. Lactate clearance was higher in survivors than in nonsurvivors patients for H0-H6
period (13 ± 38% and −13 ± 7% respectively, p = 0.021) and for the H0-H24 period (42 ± 33% and −17 ± 76%
respectively, p < 0.001). The best predictor of death at day 28 was lactate clearance for the H0-H24 period (AUC =
0.791; 95% CI 0.6-0.85). Logistic regression found that H0-H24 lactate clearance was independently correlated to a
survival status with a p = 0.047 [odds ratio = 0.35 (95% CI 0.01-0.76)].
Conclusions: During the first 24 hr in the ICU, lactate clearance was the best parameter associated with 28-day
mortality rate in septic patients. Protocol of lactate clearance-directed therapy should be considered in septic
patients, even after the golden hours.
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Severe sepsis and septic shock are a leading cause of
death in the world [1]. An early strategy of quantitative
resuscitation enables a decrease in mortality rate of sep-
tic patients, but few data are available for prolonged in-
tensive care unit (ICU) strategy [2,3]. Despite the
international recommendation of an early goal-directed
therapy [4], based on optimization of mean arterial pres-
sure, central venous pressure, urine output, and central* Correspondence: philippemarty@hotmail.com
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in any medium, provided the original work is pvenous oxygen saturation (ScvO2), mortality rate
remains high in septic shock [5-7]. There is a need to
test the prognostic value of factors that could be used
for guiding therapy after the initial resuscitation.
Static blood lactate concentrations have already been
tested in this purpose. In case of circulatory failure, such as
severe sepsis, lactate concentration is a complex result of
an anaerobic production, an aerobic production via the
Na-K ATPase channel, and a decrease in lactate utilization
[8-11]. However, several studies have described a correl-
ation between baseline lactate concentration and mortality
of ICU patients [12-15]. Although informative for severity
assessment of septic patients, basal lactate rate is useless to
guide therapy of such patients. Recently, lactate clearanceOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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outcome in severe sepsis and septic shock patients and was
proposed to guide treatment [16]. Lactate clearance as a
goal of early sepsis therapy (in the first 6 hours), compared
with central venous saturation, did not reduce the mortal-
ity of septic patients [17]. Longer duration of lactate clear-
ance monitoring might result in better results, but there is
a lack of data regarding lactate clearance in ICU after the
first 6 hours of treatment for sepsis.
We hypothesized that lactate clearance at arrival in in-
tensive care unit (after the golden hours in the emer-
gency department) could remain predictive for
outcomes. Thus, we investigated the prognostic value
for death of lactate concentration, lactate clearance, and




According to French legislation (articles L.1121-1 para-
graph 1 and R1121-2, Public Health Code), no informed
consent is needed to use data for an observational study
and informed consent from patients or relatives was
waived by the institutional review board. No change in
our current clinical practice (all measurements were
routinely required in septic shock patients) and no
randomization was performed.
Design of the study
The study was a prospective, observational case series of
adult patients. The study was conducted from April 2006
to may 2007 in a 16-bed University Hospital ICU. Con-
secutive patients admitted in this ICU for severe sepsis or
septic shock, who were from the emergency department,
were screened for the study. According to international
recommendations [4], sepsis was defined as infection plus
at least two criteria of systemic inflammation response. Se-
vere sepsis was defined as sepsis plus sepsis-induced organ
dysfunction or tissue hypoperfusion. Septic shock was
defined as sepsis-induced hypotension (systolic blood pres-
sure <90 mmHg or mean arterial pressure <70 mmHg)
persisting despite adequate fluid resuscitation. A blood
lactate concentration above 4 mmol.l-1 or oliguria (<0.5 ml.
hr-1) defined hypoperfusion. Exclusion criteria were age
≤18 years, pregnancy, and ICU-acquired severe sepsis.
Patient management in the emergency department
was performed as recommended in the international
guidelines for septic shock [4]. The inclusion of the
patient in our study began at the arrival in the ICU
(H0), i.e., after the initial management in the
emergency department. Patient management in in-
tensive care unit was gone on to reach the inter-
national guidelines goals during the first 24 hr
hospitalization [4]: 1) mean arterial pressure (MAP)≥65 mmHg and diastolic arterial pressure (DAP)
≥40 mmHg; 2) ScvO2 ≥ 70%; (3) urine output ≥0.5
ml/kg/hr.
Our standard septic shock resuscitation treatment was
administrated in sequence until the following goals were
reached:
1. Diagnosis of septic shock with lactate measurement
followed by 30–40 ml/kg crystalloid fluid loading
over 1 hour.
2. Norepinephrine titrated to obtain a MAP ≥65 mmHg
and a DAP ≥40 mmHg.
3. ScvO2 measurement: fluid loading of 500 ml
crystalloid and/or colloid every 10 min until ScvO2
reached a value ≥70%.
4. Blood transfusion if ScvO2 remained ≤ 70% and
hematocrit (Ht) ≤30%.
5. Dobutamine at a dose of 5 μg/kg/min if Ht ≥30% and
ScvO2 ≤70%.
6. After 6 hr when lactate level remained higher than 2
mmol/l: cardiac output was measured by a Pulse
Indexed Continuous Cardiac Output (PiCCo)
monitor (Pulsion, Medical Systems AG, Munich,
Germany) to optimize oxygen delivery (DO2) and
reach an ScvO2 ≥70%: successive colloid “fluid
challenge” of 500 ml over 15 min until CI variation
during the challenge became less than 15%,
transfusion if Ht ≤30% and ScvO2 ≤70%, dobutamine
if ScvO2 remained lower than 70%.
7. If ScvO2 remained lower than 70% after this DO2
optimization, attempts to lower oxygen consumption
were instituted (fever control and/or mechanical
ventilation after tracheal intubation and/or increase
in sedation and/or pain medication).
Others procedures within the first 24 hr:
1. After bacterial samples, eradication of any septic
focus with early empiric broad-spectrum antibiotics
and surgery when needed.
2. Prescription of low dose hydrocortisone if patients
were treated by norepinephrine for more than 6 hr
as recommended [4].
Data collection
Diagnosis, age, gender, and calculated Simplified Apache
Physiology Score (SAPS 2) were prospectively recorded.
Blood lactate concentration, mean arterial pressure, car-
diac index assessed with PiCCOW, arterial oxygen satur-
ation (SaO2) measured on arterial blood gas, ScvO2
measured on a central venous blood sample (superior
vena cava) were collected when patients arrived in ICU
(H0) and successively at 6, 12, and 24 hours after admis-
sion (H6, H12, and H24 after the ICU admission).
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described [16,17], the lactate clearance was defined by
the equation [(lactateinitial - lactatedelayed)/ lactateinitial] ×
100%. Lactatedelayed is blood lactate concentration mea-
sured at H6, H12, or H24. A positive value indicates a
decrease in lactate rate. ScvO2 variation was defined by
the equation [(ScvO2delayed – ScvO2initial)/ScvO2initial] ×
100%. Time of inclusion (H0) and study enrolment were
considered as the time of ICU admission. The transit
time in the emergency room between diagnosis of septic
shock and enrollment in ICU was registered.
Statistical analysis
Quantitative variables are presented as mean ± SD and
qualitative data are given as number and percentage.
Normal distribution of data was tested via Kolmogorov-
Smirnov test. The values results were not normally dis-
tributed and thus were analyzed non-parametrically.
Survivors and nonsurvivors were compared by the
Mann-Whitney U test for continuous variables and by Fish-
er’s exact test for categorical variables. To assess whether
the lactates changed over time, Friedman’s test was used.
When Friedman’s test was significant (p < 0.05), pairwise
comparisons were made using Wilcoxon’s signed-rank test.
All tests were two-sided, and p < 0.05 indicated a statistical
significance. Because lactate and SvcO2 are numerical data,
receiver-operating characteristics (ROC) curves and area
under the curve (AUC) were computed. For mortality pre-
diction, cutoff values for lactates, lactate clearance, and
SvcO2 were chosen to correspond to the best respective
Youden’s index calculated as follows: Youden’s index = sen-
sitivity + specificity −1. Results are expressed for area under
the ROC curves (AUC) as mean (95% confidence interval).Table 1 Demographic characteristics
Overall population (N = 94
Gender
M/F (%) 56 / 44
Age (yr) (mean ± SD) 58 ± 16
SAPS 2 (mean ± SD) 60 ± 17





Hemodynamic status on ICU admission (mean ± SD)
Mean arterial pressure (mmHg) 66.5 ± 10.3
Cardiac index (L/min.m2) 3.4 ± 1
Norepinephrine (μg/kg/min) 0.62 ± 0.37
Scv02 (%) 73.3 ± 9.4
ICU intensive care unit; SAPS 2 Simplified Acute Physiology Score; ScvO2 central ven
*p < 0.05 vs. survivors.A logistic regression was performed to discriminate if
SAPS II, lactate at H0, H6, H12, and H24, lactate clear-
ance H0-H6, H0-H12, and H0-H24, and norepinephrine
were independently correlated to the survival status.
Goodness of fit of the model was assessed using the
Hosmer-Lemeshow test. Statistical analysis was realized
by SAS 9.1.3 software.
Results
Patient characteristics
From April 2006 to May 2007, 96 septic shock patients
who were admitted in the ICU and who had been previ-
ously resuscitated in the emergency unit were consid-
ered eligible. Two patients were excluded (one for
pregnancy and one for age <18 years). The mean time
between severe sepsis diagnose and H0 (ICU admission)
was 8.0 ± 4.5 hours.
We analyzed the data of 94 patients with severe sepsis
or septic shock. Demographic data are provided in
Table 1. All of the patients received sedation (Ramsay
score between 3 and 5) and were mechanically venti-
lated. Norepinephrine was used in all patients. Thirty-
one patients were treated with dobutamine. Forty-two
(45%) patients died in the first 28 days. The mean SAPS
2 was 53 ± 16 in survivors versus 69 ± 15 in nonsurvivor
patients (p < 0.01). No statistical difference was noticed
for MAP and CO between survivors and nonsurvivors at
any time.
Static blood lactate and lactate clearance in survivors and
non survivors
The static blood lactate and lactate clearance are illu-
strated in Figure 1. There is a significant difference) Survivors (N = 52) Nonsurvivors (N = 42)
59 / 41 54 / 46
55 ± 17 61 ± 15
53 ± 16 69 ± 15*
14 (27) 13 (31)
18 (35) 8 (19)
2 (4) 2 (5)
18 (35) 19 (45)
68 ± 11 64 ± 10
3.4 ± 0.9 3.4 ± 1.3
0.44 ± 0.34 0.77 ± 0.5*
74.1 ± 9.2 72.3 ± 9.6
ous oxygen saturation.
Table 2 Blood lactate concentrations and lactate
clearances in survivors and non survivors during the first
24 hours in ICU
Survivors Nonsurvivors p
ScvO2 H0 (%) 74.1 ± 9.2 72.3 ± 11.6 0.39
ScvO2 H6 (%) 76.2 ± 7.1 75.2 ± 10.9 0.57
ScvO2 H12 (%) 76.4 ± 7.2 73 ± 11.5 0.07
ScvO2 H24 (%) 76.1 ± 7.5 76 ± 10.8 0.9
Variation ScvO2 H0-H6 (%) 4.19 ± 9.4 4.4 ± 14.2 0.93
Variation ScvO2 H0-H12 (%) 2.9 ± 11.6 3.4 ± 10.8 0.83
Variation ScvO2 H0-H24 (%) 3.6 ± 14.9 6.5 ± 15.8 0.5
ScvO2 variation was defined by the equation [(ScvO2delayed – ScvO2initial)/
ScvO2initial] x 100%. Results expressed as mean ± SD. Pairwise comparisons
were made using Mann-Whitney U test.
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value in survivor group (p < 0.05 for each studied
period). No significant difference was found in nonsurvi-
vor group between H6, H12, and H24 lactate value com-
pared with H0. Mean blood lactate concentrations were
lower in survivors than in nonsurvivors patients at H0
(5 ± 3.1 mmol/L vs. 6.9 ± 4.3 mmol; p = 0.049). After-
ward, blood lactate concentrations were lowers in survi-
vors than in nonsurvivors at each studied time (4.1 ± 3.2
vs. 6.9 ± 4.3 at H6; 3.6 ± 2.9 vs. 6.7 ± 4 at H12 and 3 ± 3
vs. 6.4 ± 4.5 at H24. p < 0.05 for each studied period).
Lactate clearance was 13 ± 38% in survivors and −13 ±
67% in nonsurvivors patients for the H0-H6 period (p =
0.021) and remained higher in survivors than in nonsur-
vivors for each studied period (42 ± 33% vs. −17 ± 76%;
p < 0.001 for the H0-H24 period).Static SvcO2 and SvcO2 variation in survivors and
nonsurvivors
The SvcO2 course is illustrated in Table 2. SvcO2 was
not statistically different in survivors than in nonsurvi-
vors patients at H0 and at each studied time. No signifi-
cant SvcO2 variation was noticed for any period.Diagnostic Value of static blood lactate levels, blood
lactate clearance and central venous saturation
For each period, ROC curves, AUC for lactate, and
SvcO2 were calculated (Table 3). For each period, the
most accurate cutoff value to distinguish survivors and
nonsurvivors was evaluated (Table 3). Best ROC curves
AUC were obtained for H24 static blood lactate (0.773;
95% CI 0.64-0.87) and H0-H24 lactate clearance (0.791;

























Figure 1 Time course of lactates in ICU.revealed a very poor ability to predict day-28 mortality
at any time.
Multivariate analysis between the deceased and the
survivors
Logistic regression found that only the lactate clearance
H0-H24 and norepinephrine were independently corre-
lated to a survival status with a p = 0.047 [odds ratio =
0.35 (95% CI 0.01-0.76)] and p = 0.038 [odds ratio =
2.59 (95% CI 1.05-6.41)] respectively (Table 4).
Discussion and conclusions
The current results, obtained in a population of severe
sepsis or septic shock patients, indicate and the prognos-
tic value of lactate clearance in the first 24 hr in ICU.
After initial resuscitation, ScvO2 may have poor ability
to predict death at day 28.
Mixed central venous oxygen saturation is correlated
to the central venous saturation and has been independ-
ently associated with mortality in septic shock, with
threshold values supporting those published in guide-
lines [18]. In Varpula’s study a SvcO2 < 70% is independ-
ently associated with mortality. Moreover, even if it
remains controversial, early goal-directed therapy (H0-
H6) adapted to a target of ScvO2 has decreased the mor-
tality rate in septic shock patients [19].
In the current study, neither static ScvO2 nor ScvO2
variation were predictive for death at day 28 at any time.
Other studies performed in intensive care unit after ini-
tial resuscitation support these data [20,21].
These different results are not contradictory. ScvO2
appears to be a useful tool for initial resuscitation but is
unable to distinguish survivors and nonsurvivors after
this stage. Moreover, if SvcO2 <70% [18,19] is associated
with mortality, it does not mean that SvcO2 ≥70% is
associated with survival [22]. ScvO2 seems to be a neces-
sary but not sufficient parameter to guide therapeutic
intervention in ICU after initial resuscitation. In ICU-
Table 3 Area under the ROC curves for static lactate rates and lactate clearances
AUC IC 95% Threshold Se.% CI 95% Sp.% CI 95%
ScvO2 H0 0.55 0.44–0.66 74% 53.19 38.1–67.9 64.86 47.5–79.8
ScvO2 H6 0.498 0.39–0.61 79% 72.34 57.4–84.4 42.11 26.3–59.2
ScvO2 H12 0.609 0.5–0.71 71% 88.89 75.9–96.3 36.84 21.8-54
ScvO2 H24 0.501 0.36–0.64 67% 90.32 74.2–97.8 29.17 12.7–51.1
Variation ScvO2 H0-H6 0.533 0.42–0.65 2.5% 54.55 38.9-69.6 58.82 40.7–75.3
Variation ScvO2 H0-H12 0.501 0.38–0.62 −5.2% 28.57 15.7–44.6 85.29 68.9-95
Variation ScvO2 H0-H24 0.598 0.45–0.73 4.2% 65.52 45.7-82 54.55 32.2–75.6
Lactates H0 0.613 0.5–0.71 5.4 mmol/l 76.92 63.2–87.5 54.76 38.7–70.1
Lactates H6 0.706 0.6–0.8 4.05 mmol/l 63.46 49–76.4 75.61 59.7–87.6
Lactates H12 0.729 0.62–0.82 4.2 mmol/l 75 60.4-86,3 66.67 49.8–80.9
Lactates H24 0.773 0.64–0.87 2.6 mmol/l 67.74 48.6–83.3 82.61 61.2–94.9
Lac Clear H0-H6 0.619 0.5–0.72 −7.7% 63.46 49–76.4 56.1 39.8–71.5
Lac Clear H0-H12 0.662 0.55–0.76 −44.6% 45.83 31.4–60.8 82.05 66.5–92.4
Lac Clear H0-H24 0.791 0.6–0.85 −2.1% 96.77 83.2–99.5 52.17 30.6–73.2
AUC area under the curve; CI confidence interval; Se sensibility; Sp specificity; Lac Clear lactate clearance.
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saturation is often larger than 70% despite evidence of
abnormal tissue oxygenation. This oxygen extraction
defects might be related to severe microcirculatory dis-
orders [23] and/or mitochondrial damage and/or impair-
ment of cellular respiration [24] resulting in most of the
cases in elevated ScvO2 or SvO2 values [21,25]. Low
levels reflect 1) an inadequate cardiac output with an ex-
cessive extraction of oxygen, 2) a low hemoglobin con-
centration, and/or 3) a low level of arterial oxygen
pressure (PaO2). In contrast, high levels of ScvO2 means
either 1) a very high oxygen delivery in excess of tissue
requirements, and/or 2) decreased cellular consumption
of oxygen (mitochondrial dysfunction), and/or 3) more
rarely, a large arteriovenous shunt [26]. After early re-
suscitation, ScvO2 therefore may not be sufficient to






Lactates H0 0.4 1.57 0.55 4.45
Lactates H6 0.48 0.53 0.09 3.08
Lactates H12 0.17 5.3 0.48 59
Lactates H24 0.14 0.23 0.03 1.61
Lactates Cl H0-H6 0.61 2.19 0.27 83.06
Lactates Cl H0-H12 0.1 9.89 0.05 90.15
Lactates Cl H0-H24 0.047 0.35 0.01 0.76
SAPS 2 0.47 1.03 0.96 1.1
Norepinephrine 0.038 2.59 1.05 6.41
Goodness of fit was 0.73 with the Hosmer-Lemeshow test.In a general ICU population, basal lactate concentra-
tion predicted the risk of death with a good accuracy
[27]. In 2005, Varpula et al. analyzed hemodynamic para-
meters in septic shock patients and initial lactate con-
centration was higher in nonsurvivors (3.4 vs. 2.1 mmol/
l respectively, p < 0.005) [18]. In a heterogeneous popu-
lation of septic patients, blood lactate values, with a
threshold of 4 mmo/l, were associated with in-hospital
mortality but the predictive value was poor (reported
AUC under the ROC curves = 0.56). The lactate concen-
trations were lower in survivors than in nonsurvivors all
along the first 24 hr in ICU and lactate level at H0, even
with a threshold of 6.2 mmo/l, indicating therefore a
poor ability for death prediction in septic patients.
Several authors have reported that septic patients with
the lowest lactate value at H24, even with the same ini-
tial lactate concentration, had the highest survival rate
[28-30]. For Bakker et al., the “Lactime,” defined as the
time passed with a lactate rate above a normal value,
was more predictive for death than the initial lactate
value [31]. In a cardiac arrest-resuscitated population,
lactate levels at admission were not altered in survivors
and nonsurvivors patients, whereas lactate clearances
were superior in survivors [32]. In hemodynamically
stable surgical patients, the association of an occult
hypoperfusion with a prolonged hyperlactatemia has
been associated with an increased mortality rate [14].
Dynamic assessment of metabolic values may be more
efficient for death prediction than static values. Several
studies, in severe septic patients, pointed out the value
of blood lactate clearance in the first 6 hours of resusci-
tation for the prediction of day-28 survival [16,33], but
no data are available for longer duration. In the current
study, delta lactates until the 24th hour in ICU were
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pretation of lactate clearance appeared useful even after
the “golden hours” [3,4] and enable detection of patients
with a high risk of death.
For septic patients, a lactate clearance-directed therapy
in the first 6 hours appeared as efficient as ScvO2 [17]. In
a general ICU population, an 8-hour therapy adaptation
to lactate clearance reduced the mortality rate in patients
with hyperlactatemia compared with standard therapy
[34]. No data are available for lactate-directed therapy for
longer duration, and no target can thus be proposed. In
the study of Jansen et al., a resuscitation adapted to a tar-
get of 20% decrease/2 hours for 8 hours decreased the
mortality rate [34]. In another recent study, the addition
of lactate clearance to the SSC resuscitation bundle is
associated with improved outcome [35]. According to
this study, absence of lactate clearance during the first 24
hours is associated with mortality in septic ICU patients
and should lead to therapy intensification, even in
patients who reach standard hemodynamic target.
Several limitations should be considered to interpret
this study. First, it was an observational analysis whose
results support an association and not necessarily caus-
ation. Second, data come from a single center and
institution-specific variables may have influenced the
present results. Moreover, in the current cohort, follow-
ing international recommendations [4], patients with a
low ScvO2 have received either dobutamine or transfu-
sion as adapted and these therapeutic-adaptations may
have limited our ability to confirm the value of ScvO2 as
a prognostic factor.
In conclusion, during severe sepsis or septic shock,
blood lactate concentration and lactate clearance are
both predictive for 28-day mortality. Assessment of lac-
tate clearance in the first 24 hours would be useful for
tracking patients who remained at high risk of death
despite achievement of recommended early goals deter-
mined by international recommendations. Protocols of
prolonged lactate clearance-directed therapy should be
evaluated in septic patients.
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